Table 1.
Genotype frequencies of MDM2 SNP309 in Scottish Caucasian control and breast cancer populations
| 309 SNP | Total | 309T/T | 309T/G | 309G/G |
| n | n (%) | n (%) | n (%) | |
| Control samples | 275 | 123 (44.7) | 116 (42.2) | 36 (13.1) |
| Males | 93 | 48 (51.6) | 34 (36.6) | 11 (11.8) |
| Females | 182 | 78 (42.8) | 79 (43.4) | 25 (13.7) |
| Breast cancer samples | 299 | 118 (39.5) | 141 (47.2) | 40 (13.4) |
| Breast cancer vs. Female controls OR (95% CI) |
1.0 (referent) |
1.18 (0.80 – 1.87) |
1.06 (0.60 – 1.87) |
|
| p value | - | 0.41 | 0.85 |
MDM2 SP309 genotype frequencies in Scottish Caucasian control and breast cancer populations. OR = Odds ratio, CI = Confidence interval.